| John F. Milligan |
John F. Milligan is currently the Chairman at Pacific Biosciences of California, Inc., Chairman at Ohio Wesleyan University, Chairman at Aiolos Bio, Inc., Executive Chairman at 4D Molecular Therapeutics, Inc., and Director at Biotechnology Innovation Organization. Previously, he served as the President, Chief Executive Officer & Director at Gilead Sciences, Inc. from 2016 to 2018. He also held positions as Director-Project Management at Hoffmann-La Roche, Inc. and President at Pharmasset, Inc. Milligan obtained his undergraduate degree from Ohio Wesleyan University and his doctorate degree from the University of Illinois. |
| Jonas Korlach |
Jonas Korlach is currently the Chief Scientific Officer at Pacific Biosciences of California, Inc. He received his graduate and doctorate degrees from Cornell University and his undergraduate and graduate degrees from Humboldt-Universität zu Berlin. |
| Mark David van Oene |
Mark David van Oene is currently a Director at BlueGnome Ltd., a Director at Illumina Cambridge Ltd., a Director at Dante Labs, Inc., and the Chief Operating Officer at Pacific Biosciences of California, Inc. He previously worked as the Director of Genotyping Services at Ellipsis Biotherapeutics Corp. and as the Chief Commercial Officer & SVP-Americas at Illumina, Inc. Dr. van Oene holds a doctorate degree from the University of Toronto and an undergraduate degree from the University of Western Ontario. |
| Jeff Eidel |
Jeff Eidel is currently the Chief Commercial Officer at Pacific Biosciences of California, Inc. He previously worked at Cradle Genomics, Inc. as the Head of Operations. |
| Denis Zaccarin |
Denis Zaccarin is currently working as the Senior Vice President-Product Development at Pacific Biosciences of California, Inc. He obtained a doctorate degree from the University of Ottawa in 1993. Prior to that, he completed his undergraduate degree at Université Laval in 1987 and his graduate degree at Université Laval in 1989. |
| Susan G. Kim |
Susan G. Kim is an Independent Director at Pivot Bio, Inc., Chief Financial Officer at Pacific Biosciences of California, Inc., and Advisor at Gen 1 Capital Management LLC. She previously held positions as Senior Director at Beamreach Solar, Inc., Principal at Advanced Micro Devices, Inc., Principal at Morgan Stanley, Vice President at KLA Corp., Chief Financial Officer at Katerra, Inc., and Chief Financial Officer at Data.ai, Inc. Kim received her undergraduate degree from Stanford University and her graduate degree and MBA from Kellogg School of Management. |
| Michele Farmer |
Michele Farmer is currently the Director at D2N2 Local Enterprise Partnership and the Chief Accounting Officer & Vice President at Pacific Biosciences of California, Inc. She previously worked at Illumina, Inc. as Senior Director-Accounting from 2009 to 2021 and at PricewaterhouseCoopers LLP as an Auditor from 2004 to 2009. Ms. Farmer received an undergraduate degree from San Diego State University. |
| Stephen W. Turner |
Stephen W. Turner is the founder of Pacific Biosciences of California, Inc. where he holds the title of Chief Technology Officer from 2004. Currently, he is a Member at the National Institutes of Health. Dr. Turner received his doctorate degree from Cornell University in 2000 and his undergraduate degree from the University of Wisconsin in 1990. |
| Christian O. Henry |
Christian O. Henry is currently the President, Chief Executive Officer & Director at Pacific Biosciences of California, Inc. He is also the Chairman at Wave Life Sciences Ltd. and a Director at Ginkgo Bioworks, Inc. Additionally, he holds the position of Independent Director at Wave Life Sciences USA, Inc. and Ginkgo Bioworks Holdings, Inc. In the past, Mr. Henry served as a Director at BlueGnome Ltd. from 2015 to 2017. He was also an Independent Director at Soaring Eagle Acquisition Corp. and CM Life Sciences III, Inc. Furthermore, he held the position of Vice President-Finance & Controller at Nektar Therapeutics from 1997 to 1999, and Vice President-Finance & Controller at Affymetrix, Inc. from 1999 to 2003. He served as the Chief Financial Officer at Tickets.com LLC from 2003 to 2005. Mr. Henry was the General Accounting Manager at Sugen, Inc. and a Senior Accountant at Ernst & Young LLP from 1992 to 1996. He also held the role of Senior Vice President & General Manager at Genomic Solutions, Inc. from 2012 to 2014. Lastly, he served as the Chief Commercial Officer & Executive VP at Illumina, Inc. from 2015 to 2017. Mr. Henry obtained an MBA from the University of California, Irvine in 1992. He also completed his undergraduate studies at the University of California San Diego in 1990. |
| Natalie Welch |
Natalie Welch is currently the Chief People Officer at Pacific Biosciences of California, Inc. She started this position in 2021. Prior to her current role, Ms. Welch attended The College of New Jersey where she obtained an undergraduate degree. |
| Hannah A. Valantine |
Hannah A. Valantine is the founder of Hav LLC, a company founded in 2021 where she holds the title of Principal. She is currently working as an Independent Director at CareDx, Inc., Pacific Biosciences of California, Inc., and BridgeBio Pharma, Inc., all since 2021. Additionally, she is a Professor at Stanford University School of Medicine since 1987 and a Member of the National Academy of Medicine (United States). Dr. Valantine completed her undergraduate and doctorate degrees at the University of London and also holds an undergraduate degree from Chelsea College. |
| Marshall L. Mohr |
Mr. Marshall L. Mohr, CPA, is an Independent Director at Veeva Systems, Inc., a Co-Managing Director at Intuitive Surgical Deutschland GmbH, an Independent Director at Pacific Biosciences of California, Inc. and an Executive Vice President-Global Business Services at Intuitive Surgical, Inc. He is on the Board of Directors at Veeva Systems, Inc., Pacific Biosciences of California, Inc., Fosun Kite Biotechnology Co., Ltd. and Intuitive Surgical Ltd. Mr. Mohr was previously employed as an Independent Director by Ulthera, Inc., an Independent Director by Plantronics, Inc., a Chief Financial Officer & Vice President by Adaptec, Inc., and a Managing Partner by PricewaterhouseCoopers LLP. He also served on the board at Atheros Communications, Inc. He received his undergraduate degree from Western Michigan University. |
| Randall S. Livingston |
Randall S. Livingston is currently an Independent Director at Pacific Biosciences of California, Inc., eHealthInsurance Services, Inc., Stanford Health Care, Lucile Salter Packard Children's Hospital at Stanford, and Chief Financial Officer & VP-Business Affairs at Stanford University. He previously served as Director-Corporate Development at Apple, CFO, Director & Executive Vice President at OpenTV, Independent Director at Genomic Health, Inc. and eHealth, Inc., and Chief Financial Officer at Taligent, Inc. Livingston holds an undergraduate degree and an MBA from Stanford University, as well as an MBA from Stanford Graduate School of Business. |
| Kathy P. Ordoñez |
Kathy P. Ordoñez founded Celera Diagnostics LLC in 2000, where she worked as President from 2000 to 2008. Ms. Ordoñez also currently works at Pacific Biosciences of California, Inc., as Independent Director from 2018. Ms. Ordoñez also formerly worked at RainDance Technologies, Inc., as Non-Executive Chairman & Chief Executive Officer from 2014 to 2017, Celera Corp., as President & Chief Executive Officer from 2008 to 2011, Hoffmann-La Roche, Inc., as President & Chief Executive Officer from 1985 to 2000, Roche Diagnostics Corp., as President & Chief Executive Officer from 1989 to 2009, Roche Molecular Systems, Inc., as President & Chief Executive Officer from 1991 to 2000, Quidel Corp., as Independent Director from 2019 to 2022, Advanced Medical Technology Association, as Director, Quest Diagnostics, Inc., as Senior Vice President-Diagnostic Solutions in 2013, Applera Corp., as Senior Vice President from 2000 to 2008, and Celera Group, as President. Ms. Ordoñez received her undergraduate degree in 1972 from Hartwick College and Masters Business Admin degree from Pace University. |
| Bill Ericson |
Bill Ericson is the founder of Venture Law Group LLP, founded in 1996. He is also the founder of Wildcat Venture Partners LLC, founded in 2014, where he holds the title of Managing Director. Mr. Ericson currently holds several positions. He is an Independent Director at Pacific Biosciences of California, Inc. since 2004, with his most recent title starting in 2020. He is also a Director at Northwestern University School of Law, a Board Member at HealthTap, Inc. since 2010, a Board Member at Splice Machine, Inc. since 2012, a General Partner at MDV Management Co. LLC, a Member of the Personalized Medicine Coalition, a Board Member at Carrum Health, Inc. since 2016, and a Board Member at Reach Digital, Inc. since 2017. In his former positions, Mr. Ericson served as a Director at nLIGHT, Inc. from 2000 to 2018. He was also a Director at Vykor, Inc., Tethys Bioscience, Inc., Adamas Pharmaceuticals LLC from 2005 to 2021, Finsphere Corp., Rocket Fuel, Inc. from 2008 to 2017, Navera, Inc., WorkFusion, Inc., AudienceScience, Inc. from 2002 to 2017, Verinata Health, Inc. from 2004 to 2013, Sabrix, Inc. from 2001 to 2009, RainDance Technologies, Inc. from 2007 to 2017, Visible Measures Corp. from 2007 to 2017, Sequenta, Inc. from 2008 to 2015, and Ticketfly LLC from 2011 to 2017. Mr. Ericson's education includes an undergraduate degree from Georgetown University and a graduate degree from Northwestern University School of Law. |
| Lucy Shapiro |
Lucy Shapiro is the founder of Reactive Biosciences, Inc. (founded in 2015) and Anacor Pharmaceuticals LLC (founded in 2000). She is currently an Independent Director at Pacific Biosciences of California, Inc. (since 2012) and Director & Professor at Beckman Center for Molecular & Genetic Medicine (since 1989). She also holds positions as a Director at 5metis, Inc., Professor at The Cancer Research Foundation, Inc., and Member of the National Academy of Sciences, American Academy of Arts & Sciences, National Academy of Medicine (United States), and American Academy of Microbiology. In the past, she served as Chairman-Microbiology & Immunology Department at College of Physicians & Surgeons of BC, Non-Executive Director at Smithkline Beecham Plc and GSK Plc, and Independent Director at Gen-Probe, Inc. She was also a Scientific Advisor at Hatteras Venture Partners. Dr. Shapiro received her undergraduate degree from Brooklyn College in 1962 and her doctorate from Albert Einstein College of Medicine, Inc. |
